Serial echocardiographic assessment of left ventricular mass:: how blinded should readers be?

被引:10
作者
Gosse, P
de Simone, G
Dubourg, O
Guéret, P
Schmieder, R
机构
[1] Grp Hosp St Andre, Serv Cardiol Hypertens Arterielle, F-33075 Bordeaux, France
[2] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy
[3] Hop Ambroise Pare, Serv Cardiol, Boulogne, France
[4] Hop Henri Mondor, Serv Cardiol, F-94010 Creteil, France
[5] Univ Erlangen Nurnberg, Nurnberg, Germany
关键词
hypertension; left ventricular hypertrophy; echocardiography; centralized assessment;
D O I
10.1097/00004872-200409000-00027
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives In addition to the interest of mixing the sequence of echo-exam in a central blinded review, we studied the effect that might result from group-analysis of all echocardiograms simultaneously for each patient, with their sequence kept blind. A priori, this method of reading has the potential of decreasing measurement variability. Methods We included 630 echocardiograms from 210 hypertensive patients participating in a randomized clinical trial comparing two anti hypertensive agents for regression of left ventricular (LV) hypertrophy. Three echocardiograms per patient [selection (4 weeks before; W-4), at inclusion (week 0; W0), and the end of treatment (week 52; W52)], were read twice, according to two methods, blind to centre, patient numbers and sequence of visits: (1) examination of individual serial echocardiograms, (2) examination of all-patient mixed echocardiograms. The first method was expected to increase the power of treatment comparison by reducing variability of measurements of left ventricular mass (LVM). Results Pooling echocardiograms of all patients reduces variability of LVM change under treatment: absolute LVM (W52 - W0) standard deviation was reduced by 22%. Nevertheless, despite a good between-methods agreement for LVM values at each visit (intra-class coefficient of correlation from 0.88 to 0.92), LVM change under treatment was reduced even more, by 41%. Thus, the slight decrease of variability induced by gathering the echocardiograms is associated with an even greater reduction of LVM change. Conclusions According to these findings, the 'full-blind' methodology for a central blinded review in clinical trials appears to produce the maximum power of the study with the lowest sample size. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:1813 / 1818
页数:6
相关论文
共 20 条
[1]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[2]   Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study [J].
Cuspidi, C ;
Muiesan, ML ;
Valagussa, L ;
Salvetti, M ;
Di Biagio, C ;
Agabiti-Rosei, E ;
Magnani, B ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 2002, 20 (11) :2293-2300
[3]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[4]   Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy [J].
Dahlof, B ;
Zanchetti, A ;
Diez, J ;
Nicholls, MG ;
Yu, CM ;
Barrios, V ;
Aurup, P ;
Smith, RD ;
Johansson, M .
JOURNAL OF HYPERTENSION, 2002, 20 (09) :1855-1864
[5]  
De Luca N, 2002, EUR HEART J, V23, P210
[6]   Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial [J].
de Simone, G ;
Muiesan, ML ;
Ganau, A ;
Longhini, C ;
Verdecchia, P ;
Palmieri, V ;
Agabiti-Rosei, E ;
Mancia, G .
JOURNAL OF HYPERTENSION, 1999, 17 (12) :1955-1963
[7]   Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension -: The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial [J].
Devereux, RB ;
Palmieri, V ;
Sharpe, N ;
De Quattro, V ;
Bella, JN ;
de Simone, G ;
Walker, JF ;
Hahn, RT ;
Dahlöf, B .
CIRCULATION, 2001, 104 (11) :1248-1254
[8]  
Fleiss JL, 1986, The Design and Analysis of Clinical Experiments
[9]   Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension [J].
Gosse, P ;
Guez, D ;
Guéret, P ;
Dubourg, O ;
Beauchet, A ;
de Cordoüe, A ;
Barrandon, S .
JOURNAL OF HYPERTENSION, 1998, 16 (04) :531-535
[10]   Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg:: the LIVE study [J].
Gosse, P ;
Sheridan, DJ ;
Zannad, F ;
Dubourg, O ;
Guéret, P ;
Karpov, Y ;
de Leeuw, PW ;
Palma-Gamiz, JL ;
Pessina, A ;
Motz, W ;
Degaute, JP ;
Chastang, C .
JOURNAL OF HYPERTENSION, 2000, 18 (10) :1465-1475